Medicina Integradora en el Tratamiento Oncológico

Autores/as

DOI:

https://doi.org/10.32635/2176-9745.RBC.2024v70n3.4841

Palabras clave:

Oncología Integrativa, Medicina Integrativa, Neoplasias

Resumen

A pesar de los avances en el tratamiento oncológico, el cáncer continúa siendo una enfermedad grave y debilitadora, con tratamientos que dejan secuelas físicas y emocionales. La medicina integradora surgió como un enfoque para proporcionar un cuidado más amplio y centrado en el paciente. Reconocida oficialmente en 1962 y fortalecida con aliados internacionales, como la American Society of Clinical Oncology (ASCO), la medicina integradora combina terapias convencionales y prácticas complementarias basadas en evidencias. Esta enfatiza la relación entre médico y paciente, el autocuidado y estilos de vida saludables, buscando mejorar la calidad de vida y los resultados clínicos. En los Estados Unidos, más de 50 hospitales adoptan este enfoque, integrando prácticas como yoga, meditación, nutrición y acupuntura en el manejo de síntomas comunes del cáncer, como cansancio, dolor, ansiedades y depresión. La medicina integradora no substituye al tratamiento convencional, pero sí ofrece un soporte adicional, promoviendo una atención más completa y humanizada.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Elkefi S, Asan O. The impact of patient-centered care on cancer patients’ qoc, self-efficacy, and trust towards doctors: analysis of a national survey. J Patient Exp. 2023;10:23743735231151533. doi: https://doi.org/10.1177/23743735231151533 DOI: https://doi.org/10.1177/23743735231151533

Noguchi DT, Massola MEA, Romano FRS, et al. Medicina integrativa na Oncologia. Rio de Janeiro: Atheneu; 2020.

IM Consortium [Internet]. Lake Oswego: IMH; 2024. Introdução. [acesso 2024 jul 10]. Disponível em: https://imconsortium.org/about/introduction/

Duke Health [Internet]. Raleigh: Duke University; 2004-2024©. [acesso 2024 abr 25]. Disponível em: https://www.dukehealth.org/blog/assess-your-well-being-wheel-of-health

Zorzanelli RT, Cruz MGA. O conceito de medicalização em Michel Foucault na década de 1970. Interface (Botucatu). 2018;22(66):721-31 doi: https://doi.org/10.1590/1807-57622017.0194 DOI: https://doi.org/10.1590/1807-57622017.0194

Snyderman R, Weil AT. Integrative medicine: bringing medicine back to its roots. Arch Intern Med. 2002;162(4):395-7. doi: https://doi.org/10.1001/archinte.162.4.395 DOI: https://doi.org/10.1001/archinte.162.4.395

Johnson SB, Park HS, Gross CP, et al. Use of alternative medicine for cancer and its impact on survival. J Natl Cancer Inst. 2018;110(1). doi: https://doi.org/10.1093/jnci/djx145 DOI: https://doi.org/10.1093/jnci/djx145

Camargo TC. Editorial 59-2 . Rev Bras Cancerol [Internet]. 2013[acesso 2024 jul 24];59(2):163-4. Disponível em: https://rbc.inca.gov.br/index.php/revista/article/view/1312/763

Witt CM, Balneaves LG, Cardoso MJ, et al. A Comprehensive definition for integrative oncology. J Natl Cancer Inst Monogr. 2017;2017(52). doi: https://doi.org/10.1093/jncimonographs/lgx012 DOI: https://doi.org/10.1093/jncimonographs/lgx012

Mock V, Atkinson A, Barsevick A, et al. NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park). 2000;14(11A):151-61.

Berger MJ, Ettinger DS, Aston J, NCCN guidelines insights: antiemesis, version 2. 2017. J Natl Compr Canc Netw. 2017;15(7):883-93. doi: https://doi.org/10.6004/jnccn.2017.0117 DOI: https://doi.org/10.6004/jnccn.2017.0117

Dotan E, Walter LC, Browner IS, et al. NCCN guidelines® insights: older adult oncology, version 1.2021. J Natl Compr Canc Netw. 2021;19(9):1006-19. doi: https://doi.org/10.6004/jnccn.2021.0043 DOI: https://doi.org/10.6004/jnccn.2021.0043

Lyman GH, Greenlee H, Bohlke K, et al. Integrative therapies during and after brast cancer treatment: ASCO endorsement of SIO clinical practice guideline. J Clin Oncol. 2018;36(25):2647-55. doi: https://doi. org/10.1200/jco.2018.79.2721 DOI: https://doi.org/10.1200/JCO.2018.79.2721

Mo J, Darke AK, Guthrie KA, et al. Association of fatigue and outcomes in advanced cancer: an analysis of four SWOG treatment trials. JCO Oncol Pract. 2021;17(8):e1246-57 DOI: https://doi.org/10.1200/OP.20.01096

Mao JJ, Pillai GG, Andrade CJ, et al. Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2022;72(2):144-64. doi: https://doi.org/10.3322/caac.21706 DOI: https://doi.org/10.3322/caac.21706

Jiang C, Wang H, Wang Q, et al. Prevalence of chronic pain and high-impact chronic pain in cancer survivors. JAMA Oncol. 2019;5(8):1224-6. doi: https://doi. org/10.1001/jamaoncol.2019.1439 DOI: https://doi.org/10.1001/jamaoncol.2019.1439

Santana JM, Perissinotti DMN, Oliveira Junior JO, et al. Revised definition of pain after four decade [Editorial]. Brjp. 2020;3(3):197-8. doi: https://doi. org/10.5935/2595-0118.20200191 DOI: https://doi.org/10.5935/2595-0118.20200191

National Comprehensive Cancer Network [Internet]. Plymouth Meeting: NCCN; 2024©. Guidelines 2.2024. Adult Cancer Pain. [acesso 2024 abr 25]. Disponível em: https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf

Carlson LE, Ismaila N, Addington EL, et al. Integrative oncology care of symptoms of anxiety and depression in adults with cancer: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol. 2023;41(28):4562-91. doi: https://doi.org/10.1200/jco.23.00857 DOI: https://doi.org/10.1200/JCO.23.00857

Deleemans JM, Mather H, Spiropoulos A, et al. Recent progress in mind-body therapies in cancer care. Curr Oncol Rep. 2023;25(4):293-307. doi: https://doi.org/10.1007/s11912-023-01373-w DOI: https://doi.org/10.1007/s11912-023-01373-w

Johnson SB, Park HS, Gross CP, et al. Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers. JAMA Oncol. 2018;4(10):1375-81. doi: https://doi.org/10.1001/jamaoncol.2018.2487 DOI: https://doi.org/10.1001/jamaoncol.2018.2487

Lopez G, McQuade J, Cohen L, et al. Integrative oncology physician consultations at a comprehensive cancer center: analysis of demographic, clinical and patient reported outcomes. J Cancer. 2017;8(3):395-402. doi: https://doi.org/10.7150/jca.17506 DOI: https://doi.org/10.7150/jca.17506

Crudup T, Li L, Lawson E, et al. Awareness, perceptions, and usage of whole person integrative oncology practices: similarities and differences between breast cancer patients and oncologists. J Clin Oncol. 2021;39(Sup 15):e24123. doi: https://doi.org/10.1200/JCO.2021.39.15_suppl. e2412 DOI: https://doi.org/10.1200/JCO.2021.39.15_suppl.e24123

Armstrong K, Lanni T Jr, Anderson MM, et al. Integrative medicine and the oncology patient: options and benefits. Support Care Cancer. 2018;26(7):2267-73. doi: https://doi.org/10.1007/s00520-017-4007-y DOI: https://doi.org/10.1007/s00520-017-4007-y

Publicado

2024-08-13

Cómo citar

1.
Chagas SRP. Medicina Integradora en el Tratamiento Oncológico. Rev. Bras. Cancerol. [Internet]. 13 de agosto de 2024 [citado 30 de septiembre de 2024];70(3):e-164841. Disponible en: https://rbc.inca.gov.br/index.php/revista/article/view/4841

Número

Sección

ARTÍCULOS DE OPINIÓN

Artículos más leídos del mismo autor/a